the overall relative risk estimate for conjugated estrogens first taken at least 18 months before admission , compared with never-use of any noncontraceptive estrogens , was 0.9 ( 95 % confidence interval , 0.7 to 1.1 ) .
C0014938
conjugated estrogens
C0014939
estrogens